Literature DB >> 11549157

Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses.

J M Schoonjans1, R F Brem.   

Abstract

OBJECTIVE: Large-core needle biopsy of the breast can be performed with stereotactic or ultrasonographic guidance. However, ultrasonographically guided large-core needle biopsy has notable advantages, including the absence of ionizing radiation, increased patient comfort, and greater cost-effectiveness. The purpose of this study was to evaluate the accuracy of ultrasonographically guided large-core needle biopsy for the diagnosis of breast cancer in palpable and nonpalpable breast masses.
METHODS: The study was a retrospective review of consecutive ultrasonographically guided large-core needle biopsies for indeterminate breast masses. A total 424 ultrasonographically guided core biopsies were performed in 367 patients with 1 or more breast masses. Ultrasonographically guided core biopsy was performed with a 14-gauge spring-loaded needle and a freehand technique. Correlation of ultrasonographically guided core biopsy pathologic findings with subsequent surgical pathologic findings or long-term imaging follow-up was performed.
RESULTS: Of 424 indeterminate breast lesions for which histopathologic findings were obtained by ultrasonographically guided core biopsy, 234 cancers were diagnosed. Twenty-eight additional lesions had either questionable but not definitively malignant pathologic features (n = 11) or radiologic-pathologic discordance (n = 17) and were surgically excised. Of these, 8 additional cancers were diagnosed. Patients or surgeons chose excision of 41 additional lesions that were benign on ultrasonographically guided core biopsy No cancer was found in these surgical specimens. One additional cancer was diagnosed at a 6-month imaging follow-up because of interval growth. On the basis of surgical and long-term imaging follow-up, the sensitivity of ultrasonographically guided core biopsy for the diagnosis of breast carcinoma was 99.2% (95% confidence interval, 95.6%-99.9%) in 173 palpable breast masses and 93.2% (95% confidence interval, 87.1%-97%) in 251 nonpalpable masses. In cancers diagnosed on the basis of immediate surgical excision as a result of ultrasonographically guided core biopsy that showed either questionable pathologic features or radiologic-pathologic discordance, the sensitivity of ultrasonographically guided core biopsy for the diagnosis of breast cancer was 99.2%.
CONCLUSIONS: Ultrasonographically guided large-core needle biopsy is a sensitive percutaneous biopsy method for the diagnosis of breast cancer in palpable and nonpalpable breast masses.

Entities:  

Mesh:

Year:  2001        PMID: 11549157     DOI: 10.7863/jum.2001.20.9.967

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  19 in total

Review 1.  Stereotactic and ultrasound-guided breast biopsy.

Authors:  T H Helbich; W Matzek; M H Fuchsjäger
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

2.  [Percutaneous large core breast biopsy].

Authors:  K Prechtel; J de Waal; A Nerlich; D Hölzel; J Weitz
Journal:  Pathologe       Date:  2006-05       Impact factor: 1.011

Review 3.  Accuracy of ultrasound-guided, large-core needle breast biopsy.

Authors:  G Schueller; C Schueller-Weidekamm; T H Helbich
Journal:  Eur Radiol       Date:  2008-04-15       Impact factor: 5.315

Review 4.  Comparison of the accuracy of US-guided biopsy of breast masses performed with 14-gauge, 16-gauge and 18-gauge automated cutting needle biopsy devices, and review of the literature.

Authors:  Monica L Huang; Kenneth Hess; Rosalind P Candelaria; Mohammad Eghtedari; Beatriz E Adrada; Nour Sneige; Bruno D Fornage
Journal:  Eur Radiol       Date:  2016-11-14       Impact factor: 5.315

5.  Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy.

Authors:  Y J Suh; M J Kim; E-K Kim; H J Moon; J Y Kwak; H R Koo; J H Yoon
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

6.  Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions?

Authors:  Yao-Lung Kuo; Tsai-Wang Chang
Journal:  BMC Cancer       Date:  2010-07-16       Impact factor: 4.430

7.  Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy.

Authors:  Ji Hyun Youk; Eun-Kyung Kim; Min Jung Kim; Jin Young Kwak; Eun Ju Son
Journal:  Eur Radiol       Date:  2009-10-28       Impact factor: 5.315

8.  Ultrasound-guided diagnostic breast biopsy methodology: retrospective comparison of the 8-gauge vacuum-assisted biopsy approach versus the spring-loaded 14-gauge core biopsy approach.

Authors:  Stephen P Povoski; Rafael E Jimenez; Wenle P Wang
Journal:  World J Surg Oncol       Date:  2011-08-11       Impact factor: 2.754

9.  Ultrasound-guided core-needle biopsy of breast lesions.

Authors:  Luis Apesteguía; Luis Javier Pina
Journal:  Insights Imaging       Date:  2011-04-15

10.  The negative predictive value of ultrasound-guided 14-gauge core needle biopsy of breast masses: a validation study of 339 cases.

Authors:  Charlie Zhang; Darrell R Lewis; Paola Nasute; Malcolm Hayes; Linda J Warren; Paula B Gordon
Journal:  Cancer Imaging       Date:  2012-10-31       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.